TriSalus Life Sciences^® (Nasdaq: TLSI) is an oncology company integrating novel delivery technology with immunotherapy to transform treatment for patients with liver and pancreatic tumors. Its platform includes devices that utilize a proprietary drug delivery technology and a clinical-stage investigational immunotherapy.